These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19327639)

  • 21. Actinic lesions in fishermen's lower lip: clinical, cytopathological and histopathologic analysis.
    Piñera-Marques K; Lorenço SV; Silva LF; Sotto MN; Carneiro PC
    Clinics (Sao Paulo); 2010 Apr; 65(4):363-7. PubMed ID: 20454492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix.
    Wu R; Connolly D; Ngelangel C; Bosch FX; Muñoz N; Cho KR
    Oncogene; 2000 Nov; 19(48):5543-6. PubMed ID: 11114733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic Activation of Fibroblast Growth Factor Receptor-3 and RAS Genes as Non-Overlapping Mutual Exclusive Events in Urinary Bladder Cancer.
    Pandith AA; Hussain A; Khan MS; Shah ZA; Wani MS; Siddiqi MA
    Asian Pac J Cancer Prev; 2016; 17(6):2787-93. PubMed ID: 27356691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of the mast cell density in normal oral mucosa, actinic cheilitis and lip squamous cell carcinoma.
    Gomes AP; Johann JE; Lovato GG; Ferreira AM
    Braz Dent J; 2008; 19(3):186-9. PubMed ID: 18949288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
    Logié A; Dunois-Lardé C; Rosty C; Levrel O; Blanche M; Ribeiro A; Gasc JM; Jorcano J; Werner S; Sastre-Garau X; Thiery JP; Radvanyi F
    Hum Mol Genet; 2005 May; 14(9):1153-60. PubMed ID: 15772091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.
    Zieger K; Dyrskjøt L; Wiuf C; Jensen JL; Andersen CL; Jensen KM; Ørntoft TF
    Clin Cancer Res; 2005 Nov; 11(21):7709-19. PubMed ID: 16278391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric DNA content analysis of ultraviolet light-induced squamous cell carcinomas: a comparative study of squamous cell carcinomas of the lip and those arising from other sites of sun-damaged skin.
    Tamura A; Ohnishi K; Ishikawa O; Miyachi Y
    Acta Derm Venereol; 1997 Nov; 77(6):425-7. PubMed ID: 9394973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoexpression of HDAC1, HDAC2, and HAT1 in actinic cheilitis and lip squamous cell carcinoma.
    Chrun ES; Modolo F; Vieira D; Borges-Júnior Á; Castro RG; Daniel FI
    Oral Dis; 2017 May; 23(4):505-510. PubMed ID: 28107582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.
    Custódio M; Pelissari C; Santana T; Trierveiler M
    Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1877-1883. PubMed ID: 29779037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laminin Immunostaining in Biopsies as a Useful Biomarker of Early Invasion in Actinic Cheilitis and Differential Diagnosis Between Actinic Cheilitis and Lip Cancer: New Insights.
    Vageli D; Doukas PG; Zacharouli K; Kakanis V; Strataki M; Zioga A; Skoulakis C; Koukoulis G; Ioannou M
    Head Neck Pathol; 2023 Jun; 17(2):331-338. PubMed ID: 36303015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations.
    Lott S; Wang M; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Sung MT; Tan PH; Cheng L
    Mod Pathol; 2009 May; 22(5):627-32. PubMed ID: 19287463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Density and migration of mast cells in lip squamous cell carcinoma and actinic cheilitis.
    Costa NL; Oton-Leite AF; Cheim-Júnior AP; Alencar Rde C; Bittar GO; Silva TA; Batista AC
    Histol Histopathol; 2009 Apr; 24(4):457-65. PubMed ID: 19224448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer.
    Otto W; Denzinger S; Bertz S; Gaumann A; Wild PJ; Hartmann A; Stoehr R
    Int J Cancer; 2009 Nov; 125(9):2205-8. PubMed ID: 19621447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actinic cheilitis: histopathology and p53.
    Neto Pimentel DR; Michalany N; Alchorne M; Abreu M; Borra RC; Weckx L
    J Cutan Pathol; 2006 Aug; 33(8):539-44. PubMed ID: 16919027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study.
    Ferreira PS; Rocha L; Bezerra APC; Nico MMS; Lourenço SV
    Oral Oncol; 2022 Feb; 125():105674. PubMed ID: 34929544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of DNA methyltransferases 1, 3a, and 3b in actinic cheilitis and lip squamous cell carcinomas.
    Daniel FI; Alves SR; Vieira DS; Biz MT; Daniel IW; Modolo F
    J Oral Pathol Med; 2016 Nov; 45(10):774-779. PubMed ID: 27159259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational activation of FGFR3: no involvement in the development of renal cell carcinoma.
    Stoehr CG; Stoehr R; Hartmann A; Hofstaedter F; Junker K; Blaszyk H; Wieland WF; Otto W; Denzinger S; Walter B
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):359-61. PubMed ID: 22203473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actinic cheilitis: a premalignant condition.
    Manganaro AM; Will MJ; Poulos E
    Gen Dent; 1997; 45(5):492-4. PubMed ID: 9515418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of syndecan-1 expression during lip carcinogenesis.
    Martínez A; Spencer ML; Brethauer U; Grez P; Marchesani FJ; Rojas IG
    J Oral Pathol Med; 2009 Aug; 38(7):580-3. PubMed ID: 19473447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours.
    Hida Y; Kubo Y; Arase S
    Br J Dermatol; 2009 Jun; 160(6):1258-63. PubMed ID: 19298285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.